Implementation of smart technology to improve medication adherence in patients with cardiovascular disease: is it effective?

about

Implementation of smart technology to improve medication adherence in patients with cardiovascular disease: is it effective?

Item

http://www.wikidata.org/entity/Q47224815

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Implementation of smart techno ...... ular disease: is it effective?

@en

Implementation of smart techno ...... ular disease: is it effective?

@nl

type

Item

label

Implementation of smart techno ...... ular disease: is it effective?

@en

Implementation of smart techno ...... ular disease: is it effective?

@nl

prefLabel

Implementation of smart techno ...... ular disease: is it effective?

@en

Implementation of smart techno ...... ular disease: is it effective?

@nl

P1476

Implementation of smart techno ...... ular disease: is it effective?

@en

P2093

Enno T Van der Velde

http://www.w3.org/2001/XMLSchema#string

Martin J Schalij

http://www.w3.org/2001/XMLSchema#string

Roderick W Treskes

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

A meta-analysis of the association between adherence to drug therapy and mortality

Redesigning healthcare: The 2.4 billion euro question? : Connecting smart technology to improve outcome of patients

Electronic medication packaging devices and medication adherence: a systematic review

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Determinants of patient adherence: a review of systematic reviews.

P304

119-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/17434440.2018.1421456

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Johannes W. Schoones

P577

2018-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29271661

http://www.w3.org/2001/XMLSchema#string